Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)

Andrew Weickhardt,Farshad Foroudi,Nathan Lawrentschuk, Jing Xie,Mark Sidhom,Abhijit Pal,Peter Grimison,Alison Zhang,Siobhan Ng,Colin Tang,Elizabeth Hovey, Colin Chen,George Hruby,Alexander Guminski,Margaret McJannett,Ciara Conduit,Ben Tran,Ian D. Davis,Dickon Hayne

European Urology Oncology（2023）

引用 0|浏览0

暂无评分

摘要

The combination of pembrolizumab with chemoradiation is feasible. Concurrent immunotherapy delivery does not compromise the delivery of chemoradiation. Future larger studies are required to better delineate survival advantages over chemoradiation alone.

查看译文

关键词

Immunotherapy,Bladder cancer,Chemoradiation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要